Recent Trends in the Management of Alzheimer's Disease: Current Therapeutic Options and Drug Repurposing Approaches.

Rakesh K Singh
Author Information
  1. Rakesh K Singh: Department of Pharmacology, Amity Institute of Pharmacy, Amity University, Manesar, Gurgaon-122413, Haryana, India

Abstract

Alzheimer's disease is one of the most progressive forms of dementia, ultimately leading to death in aged populations. The major hallmarks of Alzheimer's disease include deposition of extracellular amyloid senile plaques and intracellular neurofibrillary tangles in brain neuronal cells. Although there are classical therapeutic options available for the treatment of the diseases, however, they provide only a symptomatic relief and do not modify the molecular pathophysiological course of the disease. Recent research advances in Alzheimer's disease have highlighted the potential role of anti-amyloid, anti-tau, and anti-inflammatory therapies. However, these therapies are still in different phases of pre-clinical/clinical development. In addition, drug repositioning/repurposing is another interesting and promising approach to explore rationalized options for the treatment of Alzheimer's disease. This review discusses the different aspects of the pathophysiological mechanism involved in the progression of Alzheimer's disease along with the limitations of current therapies. Furthermore, this review also highlights emerging investigational drugs along with recent drug repurposing approaches for Alzheimer's disease.

Keywords

References

Eur J Cardiothorac Surg. 2013 Feb;43(2):421-7 [PMID: 22851661]
Open Neurol J. 2017 Jan 31;11:7-10 [PMID: 28567133]
Neurosci Bull. 2014 Apr;30(2):271-81 [PMID: 24664866]
J Neuropathol Exp Neurol. 2018 Mar 1;77(3):246-259 [PMID: 29378005]
Curr Med Chem. 2018;25(26):3141-3159 [PMID: 30191777]
FASEB J. 2008 Apr;22(4):1169-78 [PMID: 17998412]
Cell Discov. 2015 Aug 18;1:15021 [PMID: 27462420]
CNS Drugs. 2017 Dec;31(12):1057-1082 [PMID: 29260466]
Brain. 2016 Apr;139(Pt 4):1252-64 [PMID: 26984188]
Biol Psychiatry. 2015 Nov 15;78(10):693-701 [PMID: 25802082]
Curr Med Res Opin. 2014 Oct;30(10):2021-32 [PMID: 24983746]
Transl Neurodegener. 2018 Dec 24;7:34 [PMID: 30603085]
Neurosci Lett. 2014 Apr 17;565:30-8 [PMID: 24406153]
Ann Neurosci. 2017 May;24(1):46-54 [PMID: 28588356]
Expert Opin Ther Targets. 2019 Mar;23(3):165-176 [PMID: 30691318]
Eur J Pharmacol. 2019 Jan 5;842:208-220 [PMID: 30389631]
Brain Res Bull. 2016 Sep;126(Pt 2):207-212 [PMID: 27005438]
J Neuroinflammation. 2016 Jan 25;13:18 [PMID: 26811068]
Nature. 2017 Jan 26;541(7638):481-487 [PMID: 28099414]
Brain Behav Immun. 2017 Feb;60:188-197 [PMID: 27751869]
Front Cell Neurosci. 2015 Jan 14;8:436 [PMID: 25642165]
Alzheimers Dement. 2018 Dec;14(12):1602-1614 [PMID: 30314800]
Expert Opin Ther Targets. 2015 Apr;19(4):497-506 [PMID: 25435348]
Biomed Res Int. 2013;2013:484613 [PMID: 24455696]
Rev Neurosci. 2017 Nov 27;28(8):825-843 [PMID: 28704198]
Alzheimers Dement (N Y). 2018 May 03;4:195-214 [PMID: 29955663]
Neurotherapeutics. 2015 Jan;12(1):132-42 [PMID: 25549849]
Inflammation. 2013 Dec;36(6):1209-17 [PMID: 23695166]
Curr Med Chem. 2018 Feb 12;25(4):525-539 [PMID: 28521682]
Glia. 2016 Oct;64(10):1710-32 [PMID: 27100611]
Rev Neurosci. 2010;21(2):83-93 [PMID: 20614800]
J Alzheimers Dis. 2017;60(4):1351-1364 [PMID: 29036811]
Neuropsychiatr Dis Treat. 2015 Feb 05;11:311-5 [PMID: 25709453]
Psychoneuroendocrinology. 2018 Dec;98:95-100 [PMID: 30121550]
J Alzheimers Dis. 2015;45(4):1001-14 [PMID: 25663025]
Curr Neurovasc Res. 2016;13(1):10-21 [PMID: 26500103]
Science. 2002 Jul 19;297(5580):353-6 [PMID: 12130773]
Front Cell Neurosci. 2015 Aug 07;9:297 [PMID: 26300732]
J Alzheimers Dis. 2018;62(3):1219-1222 [PMID: 29103042]
Nat Rev Neurol. 2018 Mar;14(3):133-150 [PMID: 29377008]
Acta Neuropathol. 2016 Sep;132(3):317-38 [PMID: 27522506]
Eur J Pharmacol. 2015 Oct 5;764:571-581 [PMID: 26209363]
Alzheimers Res Ther. 2018 Jun 23;10(1):59 [PMID: 29935546]
Alzheimers Res Ther. 2016 Sep 20;8:39 [PMID: 27646601]
Curr Drug Metab. 2017;18(9):842-852 [PMID: 28595531]
Nat Rev Drug Discov. 2012 Nov;11(11):833-46 [PMID: 23123941]
Arch Toxicol. 2019 Sep;93(9):2491-2513 [PMID: 31440798]
Pharmacol Res. 2011 Apr;63(4):341-51 [PMID: 21163349]
Glia. 2016 Oct;64(10):1772-87 [PMID: 27219534]
ACS Chem Neurosci. 2015 Jun 17;6(6):814-31 [PMID: 25891385]
Transl Psychiatry. 2019 Sep 6;9(1):220 [PMID: 31492831]
Physiol Rev. 2014 Oct;94(4):1077-98 [PMID: 25287860]
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):315-9 [PMID: 20691748]
J Alzheimers Dis. 2014;42 Suppl 4:S411-9 [PMID: 25159672]
Neuropsychiatr Dis Treat. 2015 Jan 30;11:243-56 [PMID: 25673992]
Neurobiol Aging. 2018 Oct;70:203-216 [PMID: 30031930]
JAMA Netw Open. 2019 Jun 5;2(6):e196167 [PMID: 31225887]
Ann Neurol. 2012 Sep;72(3):442-54 [PMID: 23034916]
Alzheimers Dement (N Y). 2019 Jul 09;5:272-293 [PMID: 31334330]
Brain Pathol. 2008 Apr;18(2):240-52 [PMID: 18363935]
Front Mol Neurosci. 2017 Oct 24;10:339 [PMID: 29114205]
Int J Neurosci. 2014 May;124(5):307-21 [PMID: 23930978]
Metallomics. 2011 Mar;3(3):267-70 [PMID: 21298161]
Discov Med. 2012 Sep;14(76):189-97 [PMID: 23021373]
J Neurol Sci. 2004 Oct 15;225(1-2):39-49 [PMID: 15465084]
FEBS Lett. 2000 Oct 13;483(1):6-10 [PMID: 11033346]
J Alzheimers Dis. 2011;27(1):99-111 [PMID: 21765208]
J Neurochem. 2012 Jan;120 Suppl 1:71-83 [PMID: 22122681]
Int J Geriatr Psychiatry. 2013 Mar;28(3):233-41 [PMID: 22535710]
Alzheimers Dement (N Y). 2016 May 30;2(2):99-109 [PMID: 29067297]
Oxid Med Cell Longev. 2018 Jan 31;2018:6435861 [PMID: 29636850]
Neurobiol Aging. 2014 Nov;35(11):2458-2464 [PMID: 24973121]
J Histochem Cytochem. 2008 Dec;56(12):1065-73 [PMID: 18678882]
Mol Brain. 2013 Jan 28;6:6 [PMID: 23356992]
Metallomics. 2011 Mar;3(3):226-8 [PMID: 21327191]
J Neuroinflammation. 2012 Jun 26;9:145 [PMID: 22734808]
Pharmacol Biochem Behav. 2012 Nov;103(1):43-52 [PMID: 22878042]
Brief Bioinform. 2016 Mar;17(2):322-35 [PMID: 26197808]
Front Pharmacol. 2019 Aug 23;10:840 [PMID: 31507408]
Mol Med Rep. 2016 Apr;13(4):3391-6 [PMID: 26935478]
Nat Rev Neurol. 2017 Sep 29;13(10):612-623 [PMID: 28960209]
Alzheimer Dis Assoc Disord. 2012 Oct-Dec;26(4):322-8 [PMID: 22089638]
Curr Alzheimer Res. 2016;13(3):281-7 [PMID: 26679855]
Neurochem Int. 2014 Sep;75:26-31 [PMID: 24879954]
Pharmaceuticals (Basel). 2018 May 11;11(2): [PMID: 29751602]
Int J Neuropsychopharmacol. 2012 Feb;15(1):77-90 [PMID: 21329555]
Int Arch Allergy Immunol. 2012;159(4):422-7 [PMID: 22846852]
J Neurosci. 2009 Aug 26;29(34):10582-7 [PMID: 19710311]
Cell Mol Neurobiol. 2016 Mar;36(2):167-79 [PMID: 26898552]
Behav Brain Res. 2016 Sep 15;311:54-69 [PMID: 27185734]
Int J Mol Sci. 2015 Oct 29;16(11):25959-81 [PMID: 26528968]
Annu Rev Neurosci. 2016 Jul 8;39:57-79 [PMID: 27050320]
Antioxid Redox Signal. 2018 Jun 20;28(18):1669-1703 [PMID: 29402131]
Nat Rev Neurosci. 2018 Oct;19(10):610-621 [PMID: 30206330]
Neuropharmacology. 2014 Apr;79:707-14 [PMID: 24456746]
Brain Res. 2014 Nov 24;1590:97-106 [PMID: 25451090]
Pharmacol Rep. 2015 Apr;67(2):195-203 [PMID: 25712639]
J Alzheimers Dis. 2013;37(1):185-95 [PMID: 23948885]
Int J Mol Sci. 2019 Jan 17;20(2): [PMID: 30658419]
Exp Neurol. 2012 Jul;236(1):1-5 [PMID: 22575598]
J Virol. 2014 May;88(9):4698-710 [PMID: 24522913]
J Clin Invest. 2018 Oct 1;128(10):4297-4312 [PMID: 29990310]
J Neuroimmunol. 2019 Jan 15;326:62-74 [PMID: 30502599]
J Neurochem. 2017 Feb;140(4):536-549 [PMID: 27987381]
Acta Neuropathol. 2016 May;131(5):687-707 [PMID: 27038189]
J Int Neuropsychol Soc. 2017 Oct;23(9-10):818-831 [PMID: 29198280]

MeSH Term

Aged
Aging
Alzheimer Disease
Amyloid Precursor Protein Secretases
Amyloid beta-Peptides
Animals
Blood-Brain Barrier
Brain
Drug Repositioning
Humans
Inflammation
Neurofibrillary Tangles
Oxidative Stress
tau Proteins

Chemicals

Amyloid beta-Peptides
tau Proteins
Amyloid Precursor Protein Secretases

Word Cloud

Similar Articles

Cited By